1. Food and Drug Administration.Precautions necessary with central venous catheters. FDA Task Force. FDA Drug Bull July1989;15–6.
2.
2. Mansfield PF, Hohn DC, Fornage BD et al. Complications and failures of subclavian vein catheterization. N Engl J Med1994;331:1735–8.
3.
3. Sterner S, Plummer DW, Clinton J et al. A comparison of the supraclavicular approach and the infraclavicular approach for subclavian vein catheterization. Ann Emerg Med1986;15:421–4.
4.
4. Bernard RW, Stahl WM. Subclavian vein catheterizations: a prospective study. I. Noninfectious complications. Ann Surg1971;173:184–90.
5.
5. Sznajder JI, Zveibil FR, Bitterman H et al. Central vein catheterization: failure and complication rates by three percutaneous approaches. Arch Intern Med1986;146:259–61.
6.
1. Bouffard Y, Viale JP, Annat G et al. Energy expenditure in the acute renal failure patient mechanically ventilated. Intensive Care Med1987;13:401–4.
7.
1. Brown RO, Bradley JE, Bekemeyer, et al. Effect of albumin supplementation during parenteral nutrition on hospital morbidity. Crit Care Med1988;16:1177–82.
8.
2. Foley EF, Borlase BC, Dzik WH et al. Albumin supplementation in the critically ill: a prospective trial. Arch Surg1990;125:739–42.
9.
3. Kanarek KS, Williams PR, Blair C. Concurrent administration of albumin with total parenteral nutrition in sick newborn infants. JPEN1992;16:49–53.
10.
4. Golub R, Sorrento JJ, Cantu R et al. Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study. Crit Care Med1994;22:613–9.
11.
5. Blackburn GL, Driscoll DF. Time to abandon routine albumin supplementation [editorial]. Crit Care Med1992;20:157–8.
12.
6. D'Angio RG. Is there a role for albumin administration in nutrition support?Ann Pharmacother1994;28:478–82.
13.
7. Vermeulen LC, Ratko TA, Erstad BL et al. A paradigm for consensus: The University Hospital Consortium Guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med1995;155:373–9.
